Archives

img-01

Conducting Clinical Trials in Asia

With steadily increasing drug development costs and significant time spent on clinical trials, outsourcing clinical trials in Asia has rapidly become an appealing option for many firms. As developing a single drug can cost more than $200 million and take at least... Read More

img-01

China GMP and QA for Medical Devices

China's economy is growing rapidly, and so are standards of production. As its manufacturers continue to develop more sophisticated processes and products, quality standards are increasing dramatically. Medical devices are no exception. China's medical device market has grown to $6 billion, the... Read More

img-01

WHO’s Taskforce against Counterfeit Medicines in Asia

The World Health Organization (WHO) and various international partners came together in Germany November 2006 to develop a task force focused on preventing the global spread of counterfeit medicines. The International Medical Products Anti-Counterfeiting Taskforce, or IMPACT would cover legal, technological, communications... Read More

img-01

Standardizing Medical Device Nomenclature in China

The State Food and Drug Administration (SFDA) in China recently drafted the “Principles of Medical Device Nomenclature” to standardize medical device names. Medical device nomenclature is currently unregulated, which has led to confusion and misrepresentation. Medical devices which are essentially the same... Read More

img-01

China Focuses on Improving Drug Safety

On October 19, 2006, China launched a drug safety technology campaign. Recent drug-related incidents, such as the adverse reactions to antibiotic drug Xinfu manufactured in Anhui, have prompted the State Food and Drug Administration (SFDA) of China to take stringent steps towards... Read More